Newsday·3 min read·medium
The new mRNA flu shot mFlusiva is more effective. Why doctors worry Long Islanders may not get it.
D
David Olson
✦AI Summary
The FDA has approved Moderna's mRNA-based flu vaccine, mFlusiva, for adults 50 and older, showing higher efficacy than traditional vaccines. Experts express concern that public hesitation regarding mRNA technology may limit the vaccine's uptake.
To find mRNA vaccines can be used use for common diseases is "a great new confirmation,” said Dr. Martín Bäcker, a principal investigator at the NYU Langone-Long Island vaccine center. Credit: Debbie Egan-Chin
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in